Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CardioCell

- PMLiVE

Merck withdraws filing for sarcoma drug in Europe

Oncology setback sees ridaforolimus licence application pulled

- PMLiVE

Trio of wins for Leo Pharma at PMEA

Takes small company of the year, launch excellence and patient services awards

- PMLiVE

Celgene wins 2012 PMEA for excellence in ongoing brand management

Also receives recognition for internal capability development and orphan drug Vidaza

- PMLiVE

Roche wins company of the year at PMEA 2012

Also picks up team of the year at awards to recognise excellence in the pharmaceutical market

- PMLiVE

Targacept picks Solvay’s Stephen Hill to fill vacant CEO post

He will join the US clinical-stage biopharma next week

- PMLiVE

Pfizer uses augmented reflection technology for mental health campaign

Teams up with Anxiety UK to raise awareness of GAD

- PMLiVE

Pfizer concludes NextWave acquisition

Sets company up to compete in the ADHD sector

- PMLiVE

J&J’s TB drug moves closer to US approval

Bedaquiline recommended as treatment for multidrug resistant forms of the disease

Parexel signs drug development collaboration with Taiwanese hospital

Will work with the National Taiwan University Hospital

- PMLiVE

Icon launches web portal for clinical trial sites

Says iSite will improve study efficiency

Sanofi reception

Sanofi signs $900m allergy collaboration with Selecta

Companies will develop three immunotherapies targeting different allergens

Kala Pharma appoints Fovea founder Bernard Gilly to board

He previously formed the company that became Sanofi’s ophthalmology business

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links